Therapeutic Class

Drugs

Comments

Antineoplastics

bexarotene (Targretin)

Incidence varies from

1% to 5% by agent.

capecitabine (Xeloda)

dacarbazine (DTIC)

dasatinib (Sprycel)

epirubicin (Ellence)

fluorouracil (5-FU)

imatinib (Gleevec)

interferon alfa (Intron A,

Alferon N)

methotrexate (Mexate)

pentostatin (Nipent)

procarbazine (Matulane)

tretinoin oral (Vesanoid)